Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aemetis (AMTX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Aemetis (AMTX) over the last 14 years, with Q3 2025 value amounting to $546.0 million.

  • Aemetis' Total Liabilities rose 535.69% to $546.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.0 million, marking a year-over-year increase of 535.69%. This contributed to the annual value of $523.2 million for FY2024, which is 1365.1% up from last year.
  • As of Q3 2025, Aemetis' Total Liabilities stood at $546.0 million, which was up 535.69% from $529.3 million recorded in Q2 2025.
  • Aemetis' Total Liabilities' 5-year high stood at $546.0 million during Q3 2025, with a 5-year trough of $267.3 million in Q2 2021.
  • Its 5-year average for Total Liabilities is $425.8 million, with a median of $456.0 million in 2023.
  • Per our database at Business Quant, Aemetis' Total Liabilities tumbled by 929.83% in 2021 and then surged by 4992.51% in 2023.
  • Aemetis' Total Liabilities (Quarter) stood at $281.1 million in 2021, then surged by 45.5% to $409.0 million in 2022, then grew by 12.57% to $460.4 million in 2023, then rose by 13.65% to $523.2 million in 2024, then increased by 4.35% to $546.0 million in 2025.
  • Its Total Liabilities was $546.0 million in Q3 2025, compared to $529.3 million in Q2 2025 and $523.2 million in Q1 2025.